{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:16:43Z","timestamp":1791091003224,"version":"4.1.0"},"reference-count":19,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2009,9,28]],"date-time":"2009-09-28T00:00:00Z","timestamp":1254096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Ministrelli Program for Urology Research and Education"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurourology and Urodynamics"],"published-print":{"date-parts":[[2010,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Chronic pudendal nerve stimulation (CPNS) is a logical alternative particularly in those who fail sacral stimulation. We evaluated symptoms, complications, and satisfaction after CPNS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed patients having a tined lead placed at the pudendal nerve via the ischial\u2010rectal approach. Demographics, history, complications, and pre\u2010implant voiding diary data were collected. In those responding to CPNS, post\u2010implant symptom changes were measured with the Interstitial Cystitis Symptom and Problem indices (ICSI\u2010PI) and voiding diaries at 3, 6, and 12 months, and a mailed survey.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The majority of 84 patients (78.6% female; age 51.8\u2009\u00b1\u200916.9 years) had interstitial cystitis\/painful bladder syndrome, or overactive bladder. Pudendal response (\u2265\u200950% improvement) occurred in 60\/84 (71.4%), however 5 of these chose sacral neuromodulation. Almost all (93.2%) who had previously failed sacral neuromodulation responded to pudendal stimulation. Outcomes were evaluated in 55 continuing on CPNS (median follow up 24.1 months). Seven complications requiring 5 revisions, and 4 other re\u2010operations occurred. Five were explanted. Over time, significant improvements in frequency (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001), voided volume (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001), incontinence (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001), and urgency (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0019) occurred. ICSI\u2010PI scores significantly improved over 12 months (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Survey responses indicated that most still had a device (35\/40; 87.5%) continuously in use (24\/29; 82.8%), and overall bladder, pelvic pain, incontinence, urgency, and frequency symptoms had improved.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CPNS is a reasonable alternative in complex patients refractory to other therapies including sacral neuromodulation. Continued research is needed to fully assess long\u2010term outcomes and identify predictors of success. Neurourol. Urodynam. 29:1267\u20131271, 2010. \u00a9 2009 Wiley\u2010Liss, Inc.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/nau.20823","type":"journal-article","created":{"date-parts":[[2009,9,28]],"date-time":"2009-09-28T11:15:03Z","timestamp":1254136503000},"page":"1267-1271","source":"Crossref","is-referenced-by-count":149,"title":["Chronic pudendal neuromodulation: Expanding available treatment options for refractory urologic symptoms"],"prefix":"10.1002","volume":"29","author":[{"given":"Kenneth M.","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A.","family":"Killinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Boguslawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Boura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,9,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-005-0502-8"},{"key":"e_1_2_6_3_2","first-page":"1","article-title":"The relationship between subjective and objective assessments of sacral neuromodulation effectiveness in patients with urgency\u2010frequency","volume":"26","author":"Peters KM","year":"2008","journal-title":"Neurourol Urodynam"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.20131"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.20118"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.20174"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2005.07.014"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)80333-1"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2007.07082.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2004.09.003"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2005.01.051"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)80332-X"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(00)00597-5"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.07.032"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.11.047"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)65665-0"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2003.11.015"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2003.04745.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2005.09.013"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.20374"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.20823","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.20823","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/nau.20823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T17:05:06Z","timestamp":1700499906000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.20823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.1002\/nau.20823"],"URL":"https:\/\/doi.org\/10.1002\/nau.20823","archive":["Portico"],"relation":{},"ISSN":["0733-2467","1520-6777"],"issn-type":[{"value":"0733-2467","type":"print"},{"value":"1520-6777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}